Researchers at NYU Langone say a model that tracks breast tissue change across years beats single-scan and questionnaire risk tools.
A STAT First Opinion piece co-written with the Khoslas argues autonomous AI…
Nature Medicine's first lessons from a live AI-agent eye clinic in China…
The REDCap Cloud maker says its new platform moves raw trial data…
The company's sensors and AI watch for falls and changing conditions inside…
The startup's platform cuts adverse-event case processing from hours to minutes for…
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
A virtual-cell model trained on 38 million protein measurements matched real treatment…
A pathology AI trained only on frozen sections matched real surgical decisions…
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
AI is transforming women’s health by enabling earlier diagnoses, more tailored treatments, and increased attention…
The UK has joined the HealthAI Global Regulatory Network as the first founding country, positioning…
Michigan Medicine researchers have introduced NeuroVFM, a visual foundation model trained on 5.24 million clinical…
The pan-cancer foundation model outperforms 22 other methods and generalizes to treatments not seen during…
California's legislature passes SB 903, banning AI bots from offering therapy.
The American Medical Association added ten AI-related codes for 2027, even as CMS and patient…
KAIST's homegrown K-Fold model predicts protein-drug binding structures up to 25 times faster than existing…
Belgian AI drug discovery startup Sightera Biosciences raises $3.2M to advance molecular glue therapies for…